Vitamin Wagon adds eHGH to product line
The eHGH helps to reduce wrinkles, improve energy level, decrease fat, increase lean body mass, heighten sexual potency, sharpen the memory, improve sleep and enhance the immune system

The eHGH helps to reduce wrinkles, improve energy level, decrease fat, increase lean body mass, heighten sexual potency, sharpen the memory, improve sleep and enhance the immune system

The cream comprising neem oil and Hawaiian Kukui nut oil, is said to provide relief from eczema without damaging or interfering with the cellular function of the skin.

In vitro studies on iSPERSE, a cationic salt formulation, have shown delivery of consistent doses, which can have relevance to patients with lower or impaired lung function. iSPERSE

Cabozantinib inhibits MET and VEGFR2 that suppress tumor growth, metastasis and angiogenesis in preclinical models. The double-blind ‘306 trial is expected to enroll 246 CRPC patients, who will

The supplement contains a high amount of astaxanthin, an antioxidant that imparts the red color to krill. Astaxanthin, which is present in the cell membrane close to omega

The drug is an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults. The sNDA submission occurred on the back of

PI3K delta and gamma are the enzymes involved in immune cell functions, including cell proliferation, survival and cellular trafficking. The first Phase 1 trial of IPI-145 is a

Genedata Biologics advances end-to-end biologics R&D activities including antibody screening, protein engineering, and biologics production. The version 2.0 provides new protein production modules supporting production process, including molecule

Rindopepimut is an immunotherapy that targets the tumor-specific oncogene, EGFRvIII. Celldex finalized the clinical protocol for the Phase 3 randomized, double-blind study of rindopepimut in GB, after consulting

TRO40303 causes prevention of stress-induced mitochondrial permeability transition, a target implicated in cardiac reperfusion injury. The placebo-controlled, phase II proof-of-concept study in acute MI patients with large myocardial